Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/16/2025

Detecting Ketosis in Type 2 Diabetic Patients

Primary Detection Methods

  • The American Diabetes Association recommends measuring serum β-hydroxybutyrate directly for the most accurate assessment of ketosis, particularly in patients with cardiovascular disease or impaired renal function who may be on SGLT2 inhibitors 1
  • Blood ketone testing is the gold standard for detecting ketosis in type 2 diabetes, offering superior accuracy compared to urine testing 1
  • The American College of Cardiology suggests that SGLT2 inhibitors can cause euglycemic ketoacidosis, where glucose levels appear normal while dangerous ketoacidosis progresses 2, 3, 4, 1
  • Urine ketone strips detect acetoacetate and acetone but are less accurate than blood testing, and may be falsely negative in patients with impaired renal function due to decreased ketone clearance 1, 2, 3, 4

Diagnostic Criteria for Diabetic Ketoacidosis

  • The American Diabetes Association recommends confirming DKA using the triad of criteria: blood glucose >250 mg/dL, arterial pH <7.3, and serum bicarbonate <18 mEq/L 6, 2, 3, 4, 1
  • Elevated serum ketones (β-hydroxybutyrate and acetoacetate) are also a key diagnostic criterion for DKA 2, 3, 4
  • High anion gap metabolic acidosis is a characteristic feature of DKA 6

Clinical Scenarios Requiring Ketone Monitoring

  • The American College of Cardiology recommends high clinical suspicion in patients presenting with nausea, vomiting, abdominal pain, dyspnea, or generalized weakness, even when glucose appears normal 1
  • SGLT2 inhibitors increase ketone production through multiple mechanisms, including reduced insulin doses, increased glucagon leading to lipolysis, and decreased renal clearance of ketones 2, 3, 4
  • Acute illness, infection, or surgical stress require immediate testing for ketones 1, 5
  • Reduced oral intake, vomiting, or dehydration also require immediate testing for ketones 1, 5

Monitoring Protocol

  • The American Diabetes Association recommends checking blood or urine ketones when feeling unwell, and monitoring serum β-hydroxybutyrate every 2-4 hours until resolution of suspected DKA 1, 5
  • Blood glucose should be checked every 1-2 hours until stable, and electrolytes, BUN, creatinine, and venous pH require monitoring every 2-4 hours 1

Patient Education for Prevention

  • The American College of Cardiology recommends pausing SGLT2 inhibitors during acute illness, surgery, or periods of reduced oral intake, and never discontinuing insulin during illness 1, 5
  • Providing blood or urine ketone monitoring supplies for home use is essential for early detection of ketosis 1, 5
  • Warning signs requiring immediate medical attention include nausea, vomiting, or abdominal pain, dyspnea or generalized weakness, and persistent symptoms despite appropriate dietary education 1, 5, 7

Critical Pitfalls to Avoid

  • The American Diabetes Association warns against relying solely on glucose levels in patients on SGLT2 inhibitors, as euglycemic ketoacidosis can occur with glucose <250 mg/dL 2, 3, 4, 1
  • Urine ketones alone should not be used in patients with impaired renal function, as decreased renal clearance affects accuracy 2, 3, 4, 1
  • Symptoms should not be dismissed when glucose appears reassuring—ketones should be checked directly 1